Cargando…
Results and prospects of development of new polyphenolic drugs for cancer patients
The conference “Results and prospects of development of new polyphenolic drugs for cancer patients” took place at the N.N. Petrov National Medical Research Center of Oncology (PNMRCO) on May 31, 2017, and gathered researchers involved in development and evaluation of medicinal products based on the...
Autores principales: | Anisimov, Vladimir N., Larsen, Stig, Lofberg, Stig, Baldueva, Irina A., Malek, Anastasia V., Nielsen, Tea Kirkegaard, Fedoros, Elena I., Perminova, Irina V., Drobyshev, Evgeny Yu., Bykov, Vladimir N., Panchenko, Andrey V., Scherbakov, Alexander M., Belyaev, Alexey M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725075/ https://www.ncbi.nlm.nih.gov/pubmed/33400728 http://dx.doi.org/10.18632/oncotarget.22307 |
Ejemplares similares
-
Polyphenolic drug composition based on benzenepolycarboxylic acids (BP-C3) increases life span and inhibits spontaneous tumorigenesis in female SHR mice
por: Anisimov, Vladimir N., et al.
Publicado: (2016) -
The Effect of Polyphenolic Composition BP-C3 on the Efficacy and
Hematological Toxicity of Cyclophosphamide in the Chemotherapy of Mice Bearing
Soft Tissue Sarcomas Induced by Benzo[a]pyrene
por: Panchenko, Andrey V., et al.
Publicado: (2019) -
Novel water-soluble lignin derivative BP-Cx-1: identification of components and screening of potential targets in silico and in vitro
por: Fedoros, Elena I., et al.
Publicado: (2018) -
Antigenotoxic and antimutagenic effects of lignin derivative BP-C2 against dioxidine and cyclophosphamide in vivo in murine cells
por: Zhanataev, Aliy K., et al.
Publicado: (2022) -
Efficacy and Safety of Systemic and Locoregional Cisplatin Chronotherapy in Rats with Ovarian Carcinoma
por: Kireeva, Galina, et al.
Publicado: (2021)